Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maura Dandri

Showing results (31-40 of 103) with videos related to

Pageof 11
Sort By:
Science Translational Medicine|July 2, 2025
Targeting HBV with RNA interference: Paths to cureMatteo Iannacone, Cristian G Beccaria, Lena Allweiss, et al.
One Health (Amsterdam, Netherlands)|January 2, 2026
High hepatitis E virus prevalence in pig slurry samples from the north-western region of GermanyFlorian Hinte, Marc Lütgehetmann, Toni Luise Meister, et al.
Gastroenterology|September 15, 2007
Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patientsTassilo Volz, Marc Lutgehetmann, Paul Wachtler, et al.
Journal of Clinical Microbiology|July 4, 2014
Relevance of a full-length genomic RNA standard and a thermal-shock step for optimal hepatitis delta virus quantificationMaria Homs, Katja Giersch, Maria Blasi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 30, 2020
Murine hepatocytes do not support persistence of Hepatitis D virus mono-infection in vivoKatja Giersch, Lennart Hermanussen, Tassilo Volz, et al.
Hepatology (Baltimore, Md.)|January 12, 2002
Increase in de novo HBV DNA integrations in response to oxidative DNA damage or inhibition of poly(ADP-ribosyl)ationMaura Dandri, Martin R Burda, Alexander Bürkle, et al.
Antiviral Therapy|February 28, 2012
Strong antiviral activity of the new l-hydroxycytidine derivative, l-Hyd4FC, in HBV-infected human chimeric uPA/SCID miceTassilo Volz, Marc Lütgehetmann, Lena Allweiss, et al.
Tissue Engineering. Part A|May 23, 2012
Primary human hepatocytes from metabolic-disordered children recreate highly differentiated liver-tissue-like spheroids on alginate scaffoldsJeanette Bierwolf, Marc Lutgehetmann, Steffen Deichmann, et al.
Antiviral Research|July 30, 2020
A novel method to precisely quantify hepatitis B virus covalently closed circular (ccc)DNA formation and maintenanceThomas Tu, Benno Zehnder, Bingqian Qu, et al.
Gastroenterology|October 29, 2017
Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV InfectionKlaus Klumpp, Takashi Shimada, Lena Allweiss, et al.
Pageof 11

Showing results (31-40 of 103) with videos related to

Sort By:
Pageof 11
Science Translational Medicine|July 2, 2025
Targeting HBV with RNA interference: Paths to cureMatteo Iannacone, Cristian G Beccaria, Lena Allweiss, et al.
One Health (Amsterdam, Netherlands)|January 2, 2026
High hepatitis E virus prevalence in pig slurry samples from the north-western region of GermanyFlorian Hinte, Marc Lütgehetmann, Toni Luise Meister, et al.
Gastroenterology|September 15, 2007
Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patientsTassilo Volz, Marc Lutgehetmann, Paul Wachtler, et al.
Journal of Clinical Microbiology|July 4, 2014
Relevance of a full-length genomic RNA standard and a thermal-shock step for optimal hepatitis delta virus quantificationMaria Homs, Katja Giersch, Maria Blasi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 30, 2020
Murine hepatocytes do not support persistence of Hepatitis D virus mono-infection in vivoKatja Giersch, Lennart Hermanussen, Tassilo Volz, et al.
Hepatology (Baltimore, Md.)|January 12, 2002
Increase in de novo HBV DNA integrations in response to oxidative DNA damage or inhibition of poly(ADP-ribosyl)ationMaura Dandri, Martin R Burda, Alexander Bürkle, et al.
Antiviral Therapy|February 28, 2012
Strong antiviral activity of the new l-hydroxycytidine derivative, l-Hyd4FC, in HBV-infected human chimeric uPA/SCID miceTassilo Volz, Marc Lütgehetmann, Lena Allweiss, et al.
Tissue Engineering. Part A|May 23, 2012
Primary human hepatocytes from metabolic-disordered children recreate highly differentiated liver-tissue-like spheroids on alginate scaffoldsJeanette Bierwolf, Marc Lutgehetmann, Steffen Deichmann, et al.
Antiviral Research|July 30, 2020
A novel method to precisely quantify hepatitis B virus covalently closed circular (ccc)DNA formation and maintenanceThomas Tu, Benno Zehnder, Bingqian Qu, et al.
Gastroenterology|October 29, 2017
Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV InfectionKlaus Klumpp, Takashi Shimada, Lena Allweiss, et al.
Pageof 11